Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Nov 2017 for scPharmaceuticals Inc..
Filing timeline
BuySaleSun Pharmaceutical Industries Ltd
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sun Pharmaceutical Industries Ltd: trading record in brief
This profile gathers the share dealings of Sun Pharmaceutical Industries Ltd across 3 companies, led by Caraco Pharmaceutical Laboratories Ltd, Taro Pharmaceutical Industries Ltd and scPharmaceuticals Inc. In total, 21 filings cover trades dated from 31 March 2007 to 21 November 2017.
Every open-market trade on record is a purchase: 6 purchases worth €77.1M, and no sale. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €9.3M.
On 24 November 2017 came the latest disclosure, a transaction in scPharmaceuticals Inc. The latest purchase dates back some time: it was published 3,256 days ago, on 24 November 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sun Pharmaceutical Industries Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,810,536 sharesCommon StockSEC:0000899243-17-027391:0
357,143 shares@ US$14.00100.0% of flowCommon StockSEC:0000899243-17-027391:1
Canonical exit: 19 Feb 2018 (T+90)
9,710,614 sharesCommon StockSEC:0000947871-11-000599:0
544,000 sharesCommon StockSEC:0001140361-10-048630:0
5,159,765 shares@ US$16.00Ordinary SharesSEC:0000947871-10-001036:0
Canonical exit: 2 Feb 2011 (T+90)
2,333,922 sharesOrdinary SharesSEC:0000947871-10-000973:0
Canonical exit: 30 Dec 2010 (T+90)
29,382 shares@ US$7.75Ordinary SharesSEC:0000947871-10-000962:0
Canonical exit: 13 Dec 2010 (T+90)
2,405,937 shares@ US$7.75Ordinary SharesSEC:0000947871-10-000962:1
Canonical exit: 19 Dec 2010 (T+90)
2,600 shares0Founders SharesSEC:0000947871-10-000962:2
Canonical exit: 19 Dec 2010 (T+90)
544,000 sharesCommon StockSEC:0001140361-10-035066:0
1,088,000 sharesCommon StockSEC:0001169232-09-003555:0
544,000 sharesCommon StockSEC:0001169232-09-003042:0
1,632,000 sharesCommon StockSEC:0001169232-09-001598:0
1,088,000 sharesCommon StockSEC:0001169232-09-000031:0
1,632,000 sharesCommon StockSEC:0001169232-08-003386:0
544,000 sharesCommon StockSEC:0001169232-08-002307:0
1,632,000 sharesCommon StockSEC:0001169232-08-001425:0
1,088,000 sharesCommon StockSEC:0001169232-07-004570:0
1,088,000 sharesCommon StockSEC:0001169232-07-003525:0
544,000 sharesCommon StockSEC:0001169232-07-002482:0
1,632,000 sharesCommon StockSEC:0001169232-07-001763:0
21 of 21 declarations
